Windlas Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 28, 2025
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech held its 24th AGM on July 28, 2025, via video conferencing, with 55 members in attendance and all directors present. Shareholders approved 9 resolutions, including the adoption of FY25 audited financial statements and a final dividend of Rs. 5.80 per equity share for FY2024-25. They also approved the re-appointment of Executive Director Pawan Kumar Sharma and the appointment of M/s J C Bhalla & Co. as the new statutory auditors, replacing S S Kothari Mehta & Co. Three special resolutions were passed relating to the 'Windlas Plan 2025', an employee stock-based incentive scheme covering eligible employees, subsidiary employees, and grants exceeding 1% of issued capital. The meeting concluded at 2:05 PM, and consolidated voting results with the scrutinizer's report will be uploaded to stock exchange websites.
The final dividend of Rs. 5.80 per share is a positive return signal for shareholders. The introduction of the Windlas Plan 2025 (an employee incentive scheme) may lead to mild equity dilution over time but is aimed at talent retention. The auditor change is routine and should not materially affect investors.